NCT06752317View on ClinicalTrials.gov

Effect of Preoperative Intrathecal Dexamethasone Versus Dexmedetomidine on Paralytic Ileus After Major Abdominal Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

March 1, 2026

Conditions
Paralytic Ileus
Interventions
DRUG

Dexamethasone

patients will receive intrathecal dexamethasone 8 mg in 3 ml volume.

DRUG

Dexmedetomidine

patients will receive intrathecal dexmedetomidine 0.5 µg/kg in 3 ml volume.

All Listed Sponsors
lead

Assiut University

OTHER